A Phase I Study of a Daily ×3 Schedule of Intravenous Vinorelbine for Refractory Epithelial Ovarian Cancer - Concepedia

Concepedia

Publication | Closed Access

A Phase I Study of a Daily ×3 Schedule of Intravenous Vinorelbine for Refractory Epithelial Ovarian Cancer

38

Citations

17

References

1998

Year

David M. Gershenson, Thomas W. Burke, Mitchell Morris, Robert C. Bast, Al Guaspari, John Hohneker, J. Taylor Wharton

Gynecologic Oncology

OncologyIntravenous VinorelbineMedicineCancer ManagementGynecologyCancer TreatmentPharmacologyDaily ×3 ScheduleGynecology OncologyOvarian Cancer

References

	Year	Citations

Page 1